Compass Therapeutics shareholders elect Chiniara and Gray, ratify auditor

Compass Therapeutics, Inc.

Ellen V. Chiniara received 76,766,213 for and 23,754,485 withheld as director.
Mary Ann Gray received 100,051,792 for and 468,906 withheld as director.
Broker non-votes for director proposals were 17,705,143.
Ratification of CohnReznick as auditor passed 118,180,952 for, 13,785 against, 31,104 abstain.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.